From Fields to Frontiers: Tony Reder on Interferons, MS, and a Life Well-Explored
Tony Reder, MD, Professor of Neurology at the University of Chicago, helped develop interferon-β1b — the first FDA-approved biologic therapy for multiple sclerosis. His research uncovered subnormal IFN signaling in MS patients, providing the biological rationale for IFN-beta treatment, and his lab continues to unravel the striking dysregulation of gene [READ MORE]